{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:23:15Z","timestamp":1790414595743,"version":"4.1.0"},"reference-count":51,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":294,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2001,3]]},"abstract":"<jats:p>PRAME (Preferentially expressed antigen of melanoma) has been previously identified as a melanoma antigen recognized by cytotoxic T cells (CTLs) and found to be expressed in a variety of cancer cells including leukaemic cells. We have screened 98 Japanese patients with leukaemia and lymphoma for expression of the <jats:italic>PRAME<\/jats:italic> gene using semiquantitative reverse transcription polymerase chain reaction (RT\u2010PCR). Forty\u2010one patients (42%) showed high levels of PRAME expression. Eight of these patients were then monitored using real\u2010time PCR for a period of 10\u201337\u2003months. Significant reductions in the PRAME expression were observed in all patients after chemotherapy. An increased expression was detected in the two patients who relapsed, one of which was before cytological diagnosis. These changes were correlated with those of other known genetic markers, such as the <jats:italic>bcr\u2010abl<\/jats:italic> gene. Therefore, quantitative monitoring of the <jats:italic>PRAME<\/jats:italic> gene using real\u2010time PCR method may be useful for detecting minimal residual disease and to predict subsequent relapse, especially in patients without known genetic markers. In addition, a PRAME\u2010positive leukaemia cell line and fresh leukaemic cells were found to be susceptible to lysis by PRAME\u2010specific CTLs established from a patient with melanoma, suggesting that the PRAME peptide can also be a target leukaemia antigen for T cells.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2001.02670.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:32:45Z","timestamp":1047364365000},"page":"916-926","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Quantitative monitoring of the <i>PRAME<\/i> gene for the detection of minimal residual disease in leukaemia"],"prefix":"10.1111","volume":"112","author":[{"given":"Maiko","family":"Matsushita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Ogasawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-199801000-00004"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.8.2238.2238"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/13928"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.9.3522.bloodjournal8893522"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.6.1416.bloodjournal8561416"},{"key":"e_1_2_6_7_1","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1182\/blood.V83.7.1892.1892","article-title":"Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T\u2010cell receptor genes","volume":"83","author":"Cave H.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.6.1929.1929"},{"key":"e_1_2_6_9_1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/10428199809059224","article-title":"The use of the polymerase chain reaction to predict for subsequent relapse in unrelated marrow transplantation for chronic myelogenous leukemia","volume":"31","author":"Drobyski W.R.","year":"1998","journal-title":"Leukemia and Lymphoma"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401489"},{"key":"e_1_2_6_11_1","first-page":"3957","article-title":"Improved quantitation of minimal residual disease in multiple myeloma using real\u2010time polymerase chain reaction and plasmid\u2010DNA complementarity determining region III standards","volume":"58","author":"Gerard C.J.","year":"1998","journal-title":"Cancer Research"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602013340501"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)60778-6"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0596-551"},{"key":"e_1_2_6_15_1","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood.V89.9.3129","article-title":"Tumor\u2010specific idiotype vaccines in the treatment of patients with B\u2010 cell lymphoma \u2013 long\u2010term results of a clinical trial","volume":"89","author":"Hsu F.J.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80426-4"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.9.3071.3071"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.6.2267.bloodjournal8862267"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/339237a0"},{"key":"e_1_2_6_20_1","first-page":"S83","article-title":"MAGE\u20101 expression threshold for the lysis of melanoma cell lines by a specific cytotoxic T lymphocyte","volume":"7","author":"Lethe B.","year":"1997","journal-title":"Melanoma Research"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.10.4473.bloodjournal87104473"},{"key":"e_1_2_6_22_1","first-page":"1353","article-title":"Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon","volume":"9","author":"Lion T.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909303411407"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65546-0"},{"key":"e_1_2_6_25_1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1182\/blood.V90.1.290.290_290_297","article-title":"HLA\u2010DR1\u2010restricted bcr\u2010abl (b3a2)\u2010specific CD4+ T lymphocytes respond to dendritic cells pulsed with b3a2 peptide and antigen\u2010presenting cells exposed to b3a2 containing cell lysates","volume":"90","author":"Mannering S.I.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0215(19990118)80:2<219::aid-ijc10>3.3.co;2-j"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401128"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.2.673.414k30_673_683"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00823.x"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.7.2694"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.7.2450.bloodjournal8872450"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401079"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1877.x"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0398-328"},{"key":"e_1_2_6_35_1","first-page":"4090","article-title":"Heterogeneous expression of the tumor\u2010associated antigens RAGE\u20101, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T\u2010cell\u2010based immunotherapies?","volume":"58","author":"Neumann E.","year":"1998","journal-title":"Cancer Research"},{"key":"e_1_2_6_36_1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1182\/blood.V91.3.977","article-title":"Dendritic cells stimulate the expansion of bcr\u2010abl specific CD8+ T cells with cytotoxic activity against leukemic cells from patients with chronic myeloid leukemia","volume":"91","author":"Nieda M.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_37_1","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1182\/blood.V95.1.286","article-title":"HLA class I\u2010restricted lysis of leukemia cells by a CD8 (+) cytotoxic T\u2010 lymphocyte clone specific for WT1 peptide","volume":"95","author":"Ohminami H.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1521-4141(200003)30:03<803::aid-immu803>3.0.co;2-e"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401246"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400567"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.7.2602"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.7.2411"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199701303360501"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0398-321"},{"key":"e_1_2_6_45_1","first-page":"316","article-title":"Improved detection of minimal residual leukemia through modifications of polymerase chain reaction analyses based on clonospecific T cell receptor junctions","volume":"9","author":"Seriu T.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)92179-2"},{"key":"e_1_2_6_47_1","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1182\/blood.V88.10.3704.bloodjournal88103704","article-title":"Monitoring of minimal residual disease by quantitative reverse transcriptase\u2010polymerase chain reaction for AML1\u2010MTG8 transcripts in AML\u2010M2 with t(8;21)","volume":"88","author":"Tobal K.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00982.x"},{"key":"e_1_2_6_49_1","first-page":"1156","article-title":"Genes encoding tumor\u2010specific antigens are expressed in human myeloma cells","volume":"94","author":"Van Baren N.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.6.2197"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-5793(00)01112-1"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI488"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02670.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02670.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2001.02670.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T16:06:51Z","timestamp":1695830811000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2001.02670.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["10.1046\/j.1365-2141.2001.02670.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2001.02670.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3]]},"assertion":[{"value":"2001-12-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}